Financial results - MCN PHARMA CONSULTING SRL

Financial Summary - Mcn Pharma Consulting Srl
Unique identification code: 27368013
Registration number: J35/1422/2010
Nace: 7022
Sales - Ron
-
Net Profit - Ron
-890
Employees
Open Account
Company Mcn Pharma Consulting Srl with Fiscal Code 27368013 recorded a turnover of 2024 of - , with a net profit of -890 and having an average number of employees of - . The company operates in the field of Activitati de consultanta pentru afaceri si management having the NACE code 7022.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Mcn Pharma Consulting Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 47.169 53.793 52.645 25.548 0 0 0 502 0 0
Total Income - EUR 47.409 53.818 52.651 25.551 0 0 0 502 0 0
Total Expenses - EUR 19.849 17.288 20.502 9.479 5.343 709 743 3.028 1.695 890
Gross Profit/Loss - EUR 27.560 36.530 32.149 16.072 -5.343 -709 -743 -2.526 -1.695 -890
Net Profit/Loss - EUR 26.138 34.915 30.569 15.604 -5.343 -709 -743 -2.541 -1.695 -890
Employees 1 1 1 1 1 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Mcn Pharma Consulting Srl

Rating financiar

Financial Rating -
MCN PHARMA CONSULTING SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Mcn Pharma Consulting Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Mcn Pharma Consulting Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Mcn Pharma Consulting Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Mcn Pharma Consulting Srl - CUI 27368013

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 281 0 0 0 0 0 0 0 0 0
Current Assets 150.220 170.685 200.130 204.215 191.371 187.498 182.662 13.023 13.254 8.913
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 120.581 130.130 199.069 204.184 191.368 187.478 182.653 13.014 13.245 8.904
Cash 29.640 40.556 1.061 31 2 20 9 9 9 9
Shareholders Funds 134.273 34.968 30.622 15.656 10.010 9.111 8.165 5.649 3.937 3.025
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 15.598 135.717 168.419 188.027 180.840 177.876 173.997 7.374 9.317 5.888
Income in Advance 630 445 1.089 532 522 512 500 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7022 - 7022"
CAEN Financial Year 7490
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 8.913 euro in 2024 which includes Inventories of 0 euro, Receivables of 8.904 euro and cash availability of 9 euro.
The company's Equity was valued at 3.025 euro, while total Liabilities amounted to 5.888 euro. Equity decreased by -890 euro, from 3.937 euro in 2023, to 3.025 in 2024.

Risk Reports Prices

Reviews - Mcn Pharma Consulting Srl

Comments - Mcn Pharma Consulting Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.